New research has highlighted a “significant association” between low Toe Brachial Index (TBI) and the presence of coronary artery disease (CAD) in diabetic foot syndrome patients, suggesting TBI could be a valuable screening tool for identifying CAD within this population.

A new drug delivery system can cut the dosing schedule for semaglutide to just once a month, according to new research presented at EASD 2024.

The results from clinical trials evaluating once weekly insulin efsitora alfa in adults with type 2 diabetes using basal insulin for the first time have been released.

Researchers have published the first study to document the sausage toe as a prevalent presentation of diabetic toe infection.

Adults with obesity or overweight and prediabetes had a 94 per cent lower risk of progressing to type 2 diabetes after taking tirzepatide, drugmaker Eli Lilly and Co. reported.

Nine “significant” risk factors for lower extremity amputation in diabetic foot ulcer patients have been identified in new research.

The highly anticipated Hypo Awareness Week returns next month, aiming to raise vital awareness about hypoglycaemia among healthcare professionals in the UK and Ireland.

Two features of an innovative hybrid closed loop system can help people improve their glucose management at all times of the day, new research has revealed.

The highly respected diabetes consultant Dr Bob Young has sadly passed away.

Taking SLGT2 inhibitors is more effective in slowing your decline in estimated glomerular filtration rates than taking DPP4 inhibitors, scientists have said.

A data tool has been developed by the GIRFT team to help trusts and systems in England to calculate the benefits of employing diabetes inpatient specialist nurses (DISNs).

Healthcare professionals with an interest in diabetes are being invited to attend an event looking at the latest updates in endocrinology and diabetes in 2024.

Diabetes healthcare professionals are being invited to enter a prestigious awards programme which rewards and shares innovative practice.

Trend Diabetes Annual Conference - Northern Ireland 2025

Following Insulin Safety Week 2024, a series of case studies have been released to commemorate these efforts and share best practice across the healthcare sector.

A newly published guideline is now available to equip healthcare professionals with the knowledge they need to improve the treatment of adults with diabetic ketoacidosis (DKA) and hyperglycaemic hyperosmolar state (HHS).

Young people with newly diagnosed type 1 diabetes using closed-loop insulin delivery are more likely to have improved glycaemic management than those on standard therapy, a study has shown.

A new guideline on how to manage blood sugar levels in people with type 2 diabetes who require enteral feeding is now available.

Following record-breaking numbers of sites taking part in Insulin Safety Week 2024, entries are now open for the Insulin Safety Week Excellence Awards.